Aridis Pharmaceuticals, Inc.

ARDS · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$4,876$19,986$8,232$20,897
Short-Term Investments$0$0$0$0
Receivables$1,240$237$368$413
Inventory$0-$237$0-$413
Other Curr. Assets$5,510$6,810$6,517$7,070
Total Curr. Assets$11,626$26,796$15,117$27,967
Property Plant & Equip (Net)$2,147$1,357$1,258$1,006
Goodwill$0$0$0$0
Intangibles$17$22$27$32
Long-Term Investments$0$0$0$9
Tax Assets$0$0$0$526
Other NC Assets$905$1,027$0$557
Total NC Assets$3,069$2,406$1,285$2,130
Other Assets$0-$2,406-$1,285-$2,130
Total Assets$14,695$26,796$15,117$27,967
Liabilities
Payables$2,308$5,240$1,886$1,755
Short-Term Debt$4,838$696$439$0
Tax Payable$0$0$0$0
Deferred Revenue$20,173$20,838$18,748$14,602
Other Curr. Liab.$9,579$6,574$1,367$2,974
Total Curr. Liab.$36,898$33,348$22,440$19,331
LT Debt$1,292$5,282$276$0
Deferred Rev, NC$737$913$854$5,000
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$363$228$0
Total NC Liab.$2,029$6,558$1,358$5,000
Other Liabilities$0$1,000$0$0
Cap. Leases$1,830$0$0$0
Total Liabilities$38,927$40,906$23,798$24,331
Equity
Pref Stock$0$0$0$0
Common Stock$3$2$1$1
Retained Earnings-$195,666-$165,295-$123,102-$100,769
AOCI$5,051$0$0$0
Other Equity$166,380$152,183$114,420$104,404
Total Equity-$24,232-$13,110-$8,681$3,636
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$14,695$26,796$15,117$27,967
Net Debt$1,254-$14,008-$7,517-$20,897